ARTICLE | Tools & Techniques
Visualizing new partnerships
December 12, 2005 8:00 AM UTC
Seeing is Believing
In the last three to four years, the major instrument companies have concluded that the potential impact of molecular imaging on drug discovery and development justifies major investments in the field. As a result, companies such as GE Healthcare, Philips Medical Systems, Siemens Medical Solutions and Toshiba Corp. all have gotten into the act. ...